Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in pfizer

Pfizer Profit Falls 32% As Global Trial Of COVID-19 Vaccine Candidate Begins

The U.S. drugmaker said net income fell to $3.43 billion, or 61 cents per share, in the quarter, from $5.05 billion, or 91 cents per share, a year earlier.

Read More

Chinese COVID-19 Vaccine Candidate Shows Promise In Animal Tests

ARCoV is a messenger RNA vaccine which uses technology similar to candidates being developed by Moderna and BioNtech and Pfizer.

Read More

US To Pay Pfizer, Biontech $1.95 Billion For 100 Million Doses Of Covid-19 Vaccine

According to the latest data from Johns Hopkins University, worldwide, the number of coronavirus cases has surged to 15,177,477 while the death toll has risen to 621,890.

Read More

US To Pay Pfizer, Biontech $1.95 Billion For COVID-19 Vaccine

Pfizer hopes to start its pivotal late-stage trial of the vaccine as early as next week, pending regulatory approvals, Chief Scientific Officer Mikael Dolsten said in an interview.

Read More

GSK To Take 10% Stake In Germany's Curevac For $163 Million

CureVac's existing COVID-19 mRNA and rabies vaccines research programmes are not included in the deal, the companies said.

Read More

Wall Street Shifts Bets To Big Pharma As COVID-19 Vaccine Race Progresses

Companies including Pfizer and Johnson & Johnson have said they each aim to produce as many as 1 billion doses by the end of 2021.

Read More

BioNTech And Pfizer's COVID-19 Vaccine Shows Potential In Human Trial

The potential treatment is the fourth early-stage COVID-19 drug to show promise in human testing, along with projects involving Moderna, CanSino Biologics and Inovio Pharmaceuticals.

Read More

Pfizer Says Early Studies Of Potential Coronavirus Treatment Show Promise

Pfizer first revealed plans to try to develop an antiviral compound for COVID-19 in March, and later said it was working with BioNTech SE on a potential vaccine based on messenger RNA technology.

Read More

Pfizer, BioNTech To Co-Develop Potential Coronavirus Vaccine

The drugmakers will start the collaboration immediately and have signed a letter of intent for the vaccine's distribution outside China, they said in a joint statement.

Read More

Pfizer Bolsters Cancer Portfolio With $10.64 Billion Deal For Array

Under new Chief Executive Officer Albert Bourla, Pfizer has been exploring ways to diversify its pipeline as its blockbuster pain drug Lyrica loses patent protection.

Read More

Pfizer Expects Broad Interest For Consumer Health Business

Pfizer Inc, the largest U.S. drugmaker, expects no shortage of suitors for its consumer health business and said it would decide whether to sell, spin off or retain the unit next year.

Read More

Pfizer Posts Rs 60.5 Crore Net Profit In December Quarter

Revenue for the quarter ended December 31, 2016 was Rs 504 crore as compared to Rs 521 crore in the same period last year

Read More

Pfizer Boosts Cancer Drug Roster With $14 Billion Medivation Deal

The planned purchase of Medivation, with its $2.2 billion-a-year Xtandi, is the latest in a number of deals by large drugmakers willing to pay top dollar for cancer drugs that are more effective than standard, older treatments

Read More

Pfizer Beats Estimates, But Branded Drugs Disappoint

Sales of generic medicines rose 16 percent to $6.04 billion, helped by Pfizer's $16 billion purchase last year of generic hospital products company Hospira

Read More

Cipla, Wockhardt And Pfizer Among Top Winners At DigiPharmaX 2016

The awards recognise the excellence in Digital in the Pharma industry and is the country's first award of this kind

Read More